Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Porter

Showing results (301-310 of 501) with videos related to

Pageof 51
Sort By:
Nuclear Medicine Communications|June 1, 1995
Selective accumulation of strontium-89 in metastatic deposits in bone: radio-histological correlationE Ben-Josef, D R Lucas, S Vasan, et al.
Nuclear Medicine Communications|June 1, 1995
A direct measurement of strontium-89 activity in bone metastasesE Ben-Josef, R L Maughan, S Vasan, et al.
Developmental Medicine and Child Neurology|December 1, 1979
Natural history of the dislocated hip in spastic cerebral palsyM Moreau, D S Drummond, E Rogala, et al.
Cancer Research|August 12, 1998
Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteinsD G Tang, L Li, D P Chopra, et al.
The Journal of Oncology Management : the Official Journal of the American College of Oncology Administrators|June 3, 1999
Increasing market share in an information-intensive world: lessons for healthcare. Part 1: Product differentiation and information leverageA T Porter, B Nabrit-Stephens, K Steiner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 8, 1999
The cost-effectiveness of mixed beam neutron-photon radiation therapy in the treatment of adenocarcinoma of the prostateR L Maughan, B Brambs, A T Porter, et al.
The Journal of Oncology Management : the Official Journal of the American College of Oncology Administrators|May 27, 1999
The epidemiology of bony metastases: a comparison of metastatic disease rates of the past 20 yearsK B Hart, K Weiss, S Tekyi-Mensah, et al.
Urologic Oncology|June 22, 2001
Humoral mechanisms in prostate cancer: A role for FSHA T. Porter, F A C R O, E Ben-Josef
The Nebraska Medical Journal|November 1, 1984
Pulmonary carcinoid tumors: experience at one hospital for a 12-year periodT Porter, D D Neis, R D Lynch, et al.
Journal of Continuing Education in Nursing|September 1, 1989
New directions for nurse managersJ M Evers, T Porter-O'Grady, E J George, et al.
Pageof 51

Showing results (301-310 of 501) with videos related to

Sort By:
Pageof 51
Nuclear Medicine Communications|June 1, 1995
Selective accumulation of strontium-89 in metastatic deposits in bone: radio-histological correlationE Ben-Josef, D R Lucas, S Vasan, et al.
Nuclear Medicine Communications|June 1, 1995
A direct measurement of strontium-89 activity in bone metastasesE Ben-Josef, R L Maughan, S Vasan, et al.
Developmental Medicine and Child Neurology|December 1, 1979
Natural history of the dislocated hip in spastic cerebral palsyM Moreau, D S Drummond, E Rogala, et al.
Cancer Research|August 12, 1998
Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteinsD G Tang, L Li, D P Chopra, et al.
The Journal of Oncology Management : the Official Journal of the American College of Oncology Administrators|June 3, 1999
Increasing market share in an information-intensive world: lessons for healthcare. Part 1: Product differentiation and information leverageA T Porter, B Nabrit-Stephens, K Steiner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 8, 1999
The cost-effectiveness of mixed beam neutron-photon radiation therapy in the treatment of adenocarcinoma of the prostateR L Maughan, B Brambs, A T Porter, et al.
The Journal of Oncology Management : the Official Journal of the American College of Oncology Administrators|May 27, 1999
The epidemiology of bony metastases: a comparison of metastatic disease rates of the past 20 yearsK B Hart, K Weiss, S Tekyi-Mensah, et al.
Urologic Oncology|June 22, 2001
Humoral mechanisms in prostate cancer: A role for FSHA T. Porter, F A C R O, E Ben-Josef
The Nebraska Medical Journal|November 1, 1984
Pulmonary carcinoid tumors: experience at one hospital for a 12-year periodT Porter, D D Neis, R D Lynch, et al.
Journal of Continuing Education in Nursing|September 1, 1989
New directions for nurse managersJ M Evers, T Porter-O'Grady, E J George, et al.
Pageof 51